Kymera Therapeutics (KYMR) AGM 2024 summary

Opening remarks and agenda

• Chairperson welcomed attendees, introduced board members, executive team, and independent auditor.

• Outlined meeting procedures and confirmed agenda as set forth in the 2024 Notice of Annual Meeting and Proxy Statement.

Board and executive committee updates

• Introduced all board members and executive officers present at the meeting.

Shareholder proposals

• Four proposals presented: election of Class I Directors, advisory vote on executive compensation, ratification of independent auditor, and amendment to the 2020 Stock Option and Incentive Plan.